Abstract
1 The evidence for the risk of gastric erosions from aspirin is fragmentary.
2 Occult gastric bleeding following aspirin is poorly studied and the skewed distribution is unexplained; platelet factors may be relevant.
3 Overt gastric bleeding may follow aspirin; the risk is probably about one episode per two million doses.
4 There is epidemiological, clinical, experimental and histopathological evidence for an association between chronic aspirin use and chronic gastric ulcer.
5 An alternative to the Davenport hypothesis is proposed to explain the gastric action of aspirin and the non-steroidal anti-inflammatory agents.
6 Paracetamol is probably bland in its gastric actions.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BILLINGTON B. P. OBSERVATIONS FROM NEW SOUTH WALES ON THE CHANGING INCIDENCE OF GASTRIC ULCER IN AUSTRALIA. Gut. 1965 Apr;6:121–133. doi: 10.1136/gut.6.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bennett A., Stamford I. F., Unger W. G. Prostaglandin E2 and gastric acid secretion in man. J Physiol. 1973 Mar;229(2):349–360. doi: 10.1113/jphysiol.1973.sp010142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bugat R., Thompson M. R., Aures D., Grossman M. I. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats. Gastroenterology. 1976 Nov;71(5):754–759. [PubMed] [Google Scholar]
- Cameron A. J. Aspirin and gastric ulcer. Mayo Clin Proc. 1975 Oct;50(10):565–570. [PubMed] [Google Scholar]
- Cooper G. N., Jr, Meade R. C., Ellison E. H. Heidenhain pouch bleeding due to oral salicylates. Arch Surg. 1966 Jul;93(1):171–174. doi: 10.1001/archsurg.1966.01330010173021. [DOI] [PubMed] [Google Scholar]
- Dagradi A. E., Falkner R. E., Lee E. R. Multiple benign gastric ulcers. A clinical and gastroscopic study. Am J Gastroenterol. 1974 Jul;62(1):36–45. [PubMed] [Google Scholar]
- Davenport H. W. Salicylate damage to the gastric mucosal barrier. N Engl J Med. 1967 Jun 8;276(23):1307–1312. doi: 10.1056/NEJM196706082762308. [DOI] [PubMed] [Google Scholar]
- Duggan J. M. Aspirin ingestion and perforated peptic ulcer. Gut. 1972 Aug;13(8):631–633. doi: 10.1136/gut.13.8.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duggan J. M. Progress report. Aspirin in chronic gastric ulcer: an Australian experience. Gut. 1976 May;17(5):378–384. doi: 10.1136/gut.17.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duggan J. M. The analgesic syndrome. Aust N Z J Med. 1974 Aug;4(4):365–372. doi: 10.1111/j.1445-5994.1974.tb03206.x. [DOI] [PubMed] [Google Scholar]
- Floate D. A., Duggan J. M. Hour-glass stomach: an explanation. Med J Aust. 1976 Oct 30;2(18):674–676. doi: 10.5694/j.1326-5377.1976.tb130423.x. [DOI] [PubMed] [Google Scholar]
- Ivey R. J., Silvoso G. R., Krause W. J. Effect of paracetamol on gastric mucosa. Br Med J. 1978 Jun 17;1(6127):1586–1588. doi: 10.1136/bmj.1.6127.1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jick H., Porter J. Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet. 1978 Jul 8;2(8080):87–89. doi: 10.1016/s0140-6736(78)91396-x. [DOI] [PubMed] [Google Scholar]
- Jorgensen T. G. Drug consumption before perforation of peptic ulcer. Br J Surg. 1977 Apr;64(4):247–249. doi: 10.1002/bjs.1800640406. [DOI] [PubMed] [Google Scholar]
- LYNCH A., SHAW H., MILTON G. W. EFFECT OF ASPIRIN ON GASTRIC SECRETION. Gut. 1964 Jun;5:230–236. doi: 10.1136/gut.5.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lanza F., Royer G., Nelson R. An endoscopic evaluation of the effects of non-steroidal anti-inflammatory drugs on the gastric mucosa. Gastrointest Endosc. 1975 Feb;21(3):103–105. doi: 10.1016/s0016-5107(75)73812-9. [DOI] [PubMed] [Google Scholar]
- Levy M. Aspirin use in patients with major upper gastrointestinal bleeding and peptic-ulcer disease. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. N Engl J Med. 1974 May 23;290(21):1158–1162. doi: 10.1056/NEJM197405232902102. [DOI] [PubMed] [Google Scholar]
- MUIR A., COSSAR I. A. Aspirin and gastric haemorrhage. Lancet. 1959 Mar 14;1(7072):539–541. doi: 10.1016/s0140-6736(59)92308-6. [DOI] [PubMed] [Google Scholar]
- MUIR A., COSSAR I. A. Aspirin and ulcer. Br Med J. 1955 Jul 2;2(4930):7–12. doi: 10.1136/bmj.2.4930.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacDonald W. C. Correlation of mucosal histology and aspirin intake in chronic gastric ulcer. Gastroenterology. 1973 Sep;65(3):381–389. [PubMed] [Google Scholar]
- Mills D. G., Borda I. T., Philp R. B., Eldridge C. Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clin Pharmacol Ther. 1974 Feb;15(2):187–192. [PubMed] [Google Scholar]
- O'Brien P., Silen W. Effect of bile salts and aspirin on the gastric mucosal blood flow. Gastroenterology. 1973 Feb;64(2):246–253. [PubMed] [Google Scholar]
- Robert A. Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res. 1976;2:507–520. [PubMed] [Google Scholar]
- Salter R. H. Aspirin and gastrointestinal bleeding. Am J Dig Dis. 1968 Jan;13(1):38–58. doi: 10.1007/BF02239210. [DOI] [PubMed] [Google Scholar]
- St John D. J., Yeomans N. D., De Boer W. G. Chronic gastric ulcer induced by aspirin: an experimental model. Gastroenterology. 1973 Oct;65(4):634–641. [PubMed] [Google Scholar]
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
